iA Global Asset Management Inc. Makes New $258,000 Investment in Teleflex Incorporated (NYSE:TFX)

iA Global Asset Management Inc. bought a new stake in Teleflex Incorporated (NYSE:TFX) during the 4th quarter, HoldingsChannel reports. The fund bought 1,448 shares of the medical technology company’s stock, valued at approximately $258,000.

Several other hedge funds have also recently bought and sold shares of the company. Magnetar Financial LLC increased its holdings in Teleflex by 105.2% in the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company’s stock valued at $74,990,000 after buying an additional 215,961 shares during the period. Boston Partners increased its holdings in Teleflex by 1,561.5% in the 4th quarter. Boston Partners now owns 148,042 shares of the medical technology company’s stock valued at $26,351,000 after buying an additional 139,132 shares during the period. Generali Asset Management SPA SGR bought a new position in Teleflex in the 4th quarter valued at about $77,000. William Blair Investment Management LLC increased its holdings in Teleflex by 20.7% in the 4th quarter. William Blair Investment Management LLC now owns 2,654 shares of the medical technology company’s stock valued at $472,000 after buying an additional 456 shares during the period. Finally, Cibc World Markets Corp increased its holdings in Teleflex by 14.4% in the 4th quarter. Cibc World Markets Corp now owns 7,340 shares of the medical technology company’s stock valued at $1,306,000 after buying an additional 925 shares during the period. 95.62% of the stock is owned by institutional investors.

Teleflex Trading Up 1.7 %

TFX opened at $141.77 on Friday. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a market capitalization of $6.57 billion, a price-to-earnings ratio of 28.19, a PEG ratio of 1.73 and a beta of 1.21. The company’s 50 day moving average price is $163.17 and its two-hundred day moving average price is $194.04.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. As a group, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Wells Fargo & Company decreased their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. Truist Financial decreased their price target on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a report on Monday, March 3rd. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Finally, Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.